Dr. Joanne T. Beck Ph.D. serves as Independent Director of the Company. Dr. Beck is currently the Chief Operations Officer at Boston Pharmaceuticals, a privately held biopharmaceutical company, a position in which she has served since December 2019. From April 2016 to December 2019, Dr. Beck served as the Executive Vice President of Global Pharmaceutical Development and Operations at Celgene Corporation, a publicly held biopharmaceutical company. From 2012 to March 2016, Dr. Beck was Senior Vice President of Pharmaceutical Development at Shire Plc, a former publicly held biopharmaceutical company. Prior to Shire, she held positions of increasing responsibility in Global Pharmaceutical Operations at Abbott Laboratories, a publicly held pharmaceuticals and healthcare products company, and was the site head of Abbott Vascular Instruments GmbH. Prior to Abbott, Dr. Beck held positions in Process Development at Genentech and Amgen. Dr. Beck currently serves as a member of the board of directors of public biopharmaceutical company Orchard Therapeutics. Dr. Beck holds a Ph.D. in biochemistry and molecular biology from Oregon Health and Science University and completed a postdoctoral fellowship in the department of Pharmaceutical Chemistry at the University of California, San Francisco, and holds a B.A. in chemistry from Lewis and Clark College. Beck is qualified to serve on our Board of Directors because of her significant experience in the areas of process development, manufacturing and supply chain of biopharmaceuticals and her experience as an executive officer and board member in the pharmaceutical industry.
As the Independent Director of Astria Therapeutics Inc, the total compensation of Joanne Beck at Astria Therapeutics Inc is 71,046$. There are 8 executives at Astria Therapeutics Inc getting paid more, with Jill Milne having the highest compensation of 1,032,800$.
Joanne Beck is 59, he's been the Independent Director of Astria Therapeutics Inc since 2019. There are 5 older and 4 younger executives at Astria Therapeutics Inc. The oldest executive at Astria Therapeutics Inc is Michael Kishbauch, 71, who is the Independent Director.
Joanne's mailing address filed with the SEC is C/O ORCHARD THERAPEUTICS PLC, 245 HAMMERSMITH ROAD, LONDON, X0, W6 8PW.
Over the last 9 years, insiders at Astria Therapeutics Inc have traded over 0$ worth of Astria Therapeutics Inc stock and bought 3,064,797 units worth 36,777,564$ . The most active insiders traders include Jean George、Nicholas Galakatos、Lifesciences Ii, L.P.Clarus.... On average, Astria Therapeutics Inc executives and independent directors trade stock every 0 days with the average trade being worth of 2,617,339$. The most recent stock trade was executed by Lifesciences Ii, L.P.Clarus... on 30 June 2015, trading 376,695 units of CATB stock currently worth 4,520,340$.
Astria Therapeutics Inc executives and other stock owners filed with the SEC include: